UBS Group Increases D.R. Horton (NYSE:DHI) Price Target to $

D.R. Horton (NYSE:DHI – Get Free Report) had its target price increased by equities research analysts at UBS Group from $192.00 to $200.00 in a report issued on Friday, Benzinga reports. The firm currently has a “buy” rating on the construction company’s stock. UBS Group’s price target would indicate a potential upside of 40.66% from […]

Related Keywords

United States , Raymond James , Barbarak Allen , Dr Horton Company Profile , Securities Exchange Commission , Bluepath Capital Management , Rise Advisors , Fairfield Bush , Riverview Trust Co , Barclays , Dr Horton Inc , Get Free Report , Seaport Res Ptn , Director Barbara , Exchange Commission , Street Markets , South Central , Dr Horton , Nyse Dhi , Dhi , Construction , 23331a10 , Boost Price Target , Ubs Group Ag ,